Skip to main content
Clinical Trials/NCT00186771
NCT00186771
Unknown
Phase 4

Transcranial Magnetic Stimulation Used to Treat Auditory Hallucinations in Schizophrenia

St. Joseph's Healthcare Hamilton1 site in 1 country10 target enrollmentNovember 2004
ConditionsSchizophrenia

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
St. Joseph's Healthcare Hamilton
Enrollment
10
Locations
1
Primary Endpoint
Hoffman Auditory Hallucination Scale
Last Updated
14 years ago

Overview

Brief Summary

Schizophrenia is a chronic, severe, and disabling brain disease. Auditory hallucinations are the most frequent symptoms with an incident of 50% to 70% in patients.

Transcranial Magnetic Stimulation (TMS) can significantly reduce symptoms of schizophrenia. TMS is capable of inducing changes in the electrical activities of the brain in humans.

The purpose of this trial is to study the use of TMS to decrease auditory hallucinations in schizophrenia.

Detailed Description

We hypothesize that: True treatment with rTMS will have significant decrease in auditory hallucinations versus sham treatment over the temporoparietal cortex. FMRI will highlight areas of activation with auditory hallucinations distinct from the area identified by Hoffman's scalp based method. Cortical inhibition as measured by paired pulse TMS will be increased after true TMS but not sham TMS.

Registry
clinicaltrials.gov
Start Date
November 2004
End Date
January 2015
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Schizophrenia
  • Auditory hallucinations occuring more than 5 times per day
  • Adequate (6 weeks) trial of antipsychotic medication
  • Including at least 1 atypical antipsychotic medication
  • Medication stable for 4 weeks prior to commencement of the study
  • Competent to consent

Exclusion Criteria

  • history of seizure disorder in patient or first degree relative
  • recent head injury
  • Acute suicidality
  • Alcohol or substance abuse
  • Implanted pacemaker or metal in head or neck
  • Pregnancy

Outcomes

Primary Outcomes

Hoffman Auditory Hallucination Scale

Time Frame: weekly

A series of 7 questions to identify the intensity and severity of the hallucinations

Secondary Outcomes

  • Positive and Negative Syndrome Scale for Schizophrenia (PANSS)(2 weeks)

Study Sites (1)

Loading locations...

Similar Trials